poisar

Stocks · News reference

Canaccord Genuity Maintains Buy on Core Scientific, Raises Price Target to $36

BenzingaJul 29, 2026, 10:23 AMBenzinga Newsdesk

Canaccord Genuity analyst Joseph Vafi maintains Core Scientific (NASDAQ:CORZ) with a Buy and raises the price target from $30 to $36.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 29, 2026, 10:23 AM
Checked
Jul 29, 2026, 10:22 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading